2021
How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19?
Shafeghat M, Aminorroaya A, Rezaei N. How Stable Ischemic Heart Disease Leads to Acute Coronary Syndrome in COVID-19? Acta BioMedica 2021, 92: e2021512. PMID: 34738559, PMCID: PMC8689303, DOI: 10.23750/abm.v92i5.12013.Peer-Reviewed Original ResearchConceptsAcute coronary syndromeCoronary artery diseaseStable coronary artery diseaseCoronary syndromeProgression to acute coronary syndromesCytotoxic T-cell lymphocytesIncidence of myocardial injuryOut-of-hospital cardiac arrestStable ischemic heart diseaseProgression of stable coronary artery diseaseIncreased mortality risk of patientsRate of out-of-hospital cardiac arrestMalignant ventricular arrhythmiasT-cell lymphocytesMortality risk of patientsRisk of patientsIschemic heart diseaseWorld Health Organization protocolCOVID-19 patientsIncreased mortality riskVentricular arrhythmiasSystemic inflammationCardiac arrestCytokine releaseFollow-up
2020
Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists
Aminorroaya A, Vasheghani-Farahani A, Masoudkabir F, Roayaei P. Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists. Journal Of Interventional Cardiac Electrophysiology 2020, 60: 1-7. PMID: 32712900, DOI: 10.1007/s10840-020-00837-4.Peer-Reviewed Original ResearchConceptsSudden cardiac deathImplantable cardioverter-defibrillatorHypertrophic cardiomyopathySudden cardiac death risk stratificationEuropean Society of Cardiology guidelinesPrimary prevention implantable cardioverter-defibrillatorRisk stratification of patientsAmerican College of Cardiology Foundation/American Heart AssociationImplantable cardioverter-defibrillator implantationHigh-risk patientsStratification of patientsImplantation of primary prevention implantable cardioverter-defibrillatorsCardioverter-defibrillator implantationCardiology guidelinesRisk patientsVentricular arrhythmiasClinical outcomesCardiac deathCardioverter-defibrillatorHeart AssociationAmerican CollegePrimary preventionPatientsCare practitionersEuropean Society